At InfinixBio, we’re passionate about the incredible world of scientific research and diagnostics, where assay development and validation play a pivotal role. Assays are developed for FDA approval, making them a crucial stage of the process.
The development and validation of assays allow us to determine the presence, quantity, or activity of a target substance with precision.
Assays provide insights into biological processes, disease states, and the effectiveness of potential treatments. Safety assays, efficacy assays, and toxicity assays are developed to determine these assays.
InfinixBio makes this process of developing assays and carrying out sample analysis faster, enabling companies to head to market quicker.
As per Danaher, the first step in the assay development process is identification and validation of targets.
Choosing the right target or analyte determines the assay’s applicability and relevance.
The target must have a known and significant role in the biological process or disease state being tested.
Once the target is selected, the next step is reagent preparation.
The preparation of these reagents requires meticulous attention to detail to ensure that they meet the necessary purity, specificity, and stability standards.
This involves validating the reagents through tests to confirm that they perform consistently across different experiments and conditions.
The design of the test system is where the theoretical meets the practical. Strategic planning is essential in laying out how the assay will be conducted.
The Medical Device & Diagnostic Industry describes this process as defining the variables, establishing appropriate controls, and considering the statistical methods that will be used to analyze the data.
InfinixBio has a proven track record of overcoming lab-related challenges while guiding clients on a successful regulatory pathway. Learn more about our story.
So, what exactly is assay qualification? Think of it as the bridge between the lab bench and the real world.
It’s where we test the waters, making sure our assay can do its job under the conditions it will actually face.
This is distinct from validation, which is more about proving that the assay meets all the technical specifications and standards required.
Development is the brainstorming phase, where we’re figuring out the best approach to measuring our target analyte.
When we talk about designing experiments for assay qualification, we’re looking at a few key factors.
Here, we’re considering everything from the biological matrix we’re working in (like blood, urine, or saliva) to the expected range of the target analyte. The goal is to mimic the real-world conditions as closely as possible.
It’s also all about the numbers. We need to plan our experiments in a way that allows us to statistically prove that our assay can detect what we’re looking for, at the levels we expect to find it.
Lastly, we must set our benchmarks. Having robust controls and reference materials means we can be confident our assay is giving us accurate results.
Once we’ve run our experiments, it’s time to crunch the numbers. This stage is crucial for:
The importance of clear and concise documentation in assay qualification cannot be overstated.
Not only does it ensure that we’re meeting all the necessary regulatory compliance requirements, but it also means that our work can be verified.
Read More: The Role Of InfinixBio In Accelerating Pre-Clinical Research
Assay validation translates into trust. In the world of scientific research, diagnostics, or any field that relies on assay data, trust in the results is paramount.
Validation is how we build that trust. It means our assays can consistently deliver accurate, reliable, and reproducible results.
Beyond the operational aspect, validated assays help us comply with regulatory standards, which is crucial for any product or service to make its way to the market successfully.
Every assay begins with a question: Can it be done?
The feasibility assessment involves determining if the requirements of a project can be met within the budget, schedule, and performance constraints of the project.
(Assay Development needs to be added before Optimization)
Once we’ve established that our assay is feasible, the next step is optimization. Optimization involves tweaking and fine-tuning variables to enhance the assay’s overall performance.
We might adjust reaction conditions, experiment with different reagents, or try new detection methods.
Finally, we reach the validation stage. This is where we rigorously test our optimized assay against predefined criteria to confirm its performance. Validation is about proving that the assay works in the real world.
At InfinixBio, we work with clients as a cross-functional interdisciplinary team to advance to the regulatory approval process. With us, you’re involved in every step of the process.
Assay validation involves an examination of several critical parameters to ensure the assay’s reliability and efficacy.
These parameters include precision, accuracy, specificity, sensitivity, and robustness among others (Raposo & Ibelli-Bianco, 2020).
Adhering to regulatory guidelines is a non-negotiable.
Bodies like the FDA in the United States, EMA in Europe, and others across the globe have set standards and guidelines that assays must meet to be approved for use.
These regulations ensure that assays are safe for clinical use.
Here’s everything you need to know about the early drug development process at InfinixBio.
Common challenges include:
To navigate through these challenges, a proactive approach is key. This might include:
You Might Like: From Concept To Reality: The Journey Of Assay Development And Validation With InfinixBio
The FDA establishes the benchmarks for bioanalytical method validation.
These guidelines ensure that assays are capable of accurately measuring the parent and active metabolites in drugs, taking into account the potential matrix effects that could influence assay results.
While the FDA guidelines provide a framework for assay validation within the United States, global efforts, such as those undertaken by the International Council for Harmonisation (ICH), aim to align regulatory standards across borders.
This global approach ensures that assays are precise, accurate, and universally accepted.
The horizon of assay development is continuously expanding with technologies like CRISPR and single-cell analysis.
Such technologies enhance the sensitivity and specificity of assays, opening new pathways for diagnostic and therapeutic applications.
Another trend is the shift towards automation and high-throughput screening methods. These advancements are transforming assay development by increasing efficiency and reproducibility.
At InfinixBio, the commitment to excellence in assay development and validation is at the core of everything we do. Every assay we develop meets the highest standards of quality, reliability, and regulatory compliance.
We encourage researchers, biotechnologists, and innovators in the scientific community to explore our approach and see how our collaboration will enhance your projects and research endeavors.
Learn more about our commitment and approach to assay development services here. For specific inquiries or to discuss your project needs, get in touch with us today.
Assay development services involve creating tests to detect specific substances. Validation ensures these tests consistently produce accurate results.
It confirms an assay’s reliability, ensuring results are trustworthy for diagnostics or research, and meets regulatory standards.
Key parameters include specificity, accuracy, precision, sensitivity, and robustness, ensuring the assay performs as expected.
Regulatory guidelines, like those from the FDA, set quality and performance standards, ensuring assays are safe and effective for use.
Trends include using technologies like CRISPR and single-cell analysis for more precise assays, and automation for higher efficiency.
Our experienced lab team is here to help. Reach out today to learn more.
Back to Blog
